Literature DB >> 4698260

N-hexyl-O-glucosyl sphingosine, an inhibitor of glucosyl ceramide -glucosidase.

J S Erickson, N S Radin.   

Abstract

A synthetic analog of glucocerebroside, N-hexyl-O-glucosyl sphingosine, was found to inhibit the glucosidase in rat spleen that hydrolyzes glucocerebroside. At a concentration of 1 micro m, the analog inhibited the enzyme by 48%. The mode of action appeared to be competitive, probably aided by tight binding of the amine group to a carboxyl group near the enzyme's active site. Increasing or decreasing the chain length of the n-alkyl group attached to the nitrogen atom led to decreased effectiveness. The inhibitory effect was maximal at pH 7.0, but it was still considerable at the enzyme's optimal pH, 5.0. It is suggested that the compound may be useful for inducing an animal model of Gaucher's disease.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4698260

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  9 in total

1.  Pitfalls in the use of artificial substrates for the diagnosis of Gaucher's disease.

Authors:  Y Ben-Yoseph; H L Nadler
Journal:  J Clin Pathol       Date:  1978-11       Impact factor: 3.411

2.  Multiple glycosidase deficiencies in a case of juvenile (type 3) Gaucher disease.

Authors:  Y B Chiao; G M Hoyson; S P Peters; R E Lee; W Diven; J V Murphy; R H Glew
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

3.  Alternate pathways of cerebroside catabolism.

Authors:  Y N Lin; N S Radin
Journal:  Lipids       Date:  1973-12       Impact factor: 1.880

4.  Identification of a feedback loop involving β-glucosidase 2 and its product sphingosine sheds light on the molecular mechanisms in Gaucher disease.

Authors:  Sophie Schonauer; Heinz G Körschen; Anke Penno; Andreas Rennhack; Bernadette Breiden; Konrad Sandhoff; Katharina Gutbrod; Peter Dörmann; Diana N Raju; Per Haberkant; Mathias J Gerl; Britta Brügger; Hila Zigdon; Ayelet Vardi; Anthony H Futerman; Christoph Thiele; Dagmar Wachten
Journal:  J Biol Chem       Date:  2017-03-03       Impact factor: 5.157

5.  Endogenous β-glucocerebrosidase activity in Abca12⁻/⁻epidermis elevates ceramide levels after topical lipid application but does not restore barrier function.

Authors:  Jorge F Haller; Paul Cavallaro; Nicholas J Hernandez; Lee Dolat; Stephanie J Soscia; Ruth Welti; Gregory A Grabowski; Michael L Fitzgerald; Mason W Freeman
Journal:  J Lipid Res       Date:  2013-11-30       Impact factor: 5.922

6.  Characterization of the phospholipid requirement of a rat liver beta-glucosidase.

Authors:  A Basu; R H Glew
Journal:  Biochem J       Date:  1984-12-01       Impact factor: 3.857

7.  Human acid beta-glucosidase: isolation and amino acid sequence of a peptide containing the catalytic site.

Authors:  T Dinur; K M Osiecki; G Legler; S Gatt; R J Desnick; G A Grabowski
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

8.  Diagnosis of metachromatic leukodystrophy, Krabbe disease, and Farber disease after uptake of fatty acid-labeled cerebroside sulfate into cultured skin fibroblasts.

Authors:  T Kudoh; D A Wenger
Journal:  J Clin Invest       Date:  1982-07       Impact factor: 14.808

9.  A Guided Tour of the Structural Biology of Gaucher Disease: Acid-β-Glucosidase and Saposin C.

Authors:  Raquel L Lieberman
Journal:  Enzyme Res       Date:  2011-11-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.